Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Ebglyss (lebrikizumab-lbkz) is a humanized monoclonal antibody that targets interleukin-13 (IL-13), a cytokine involved in the inflammatory response associated with atopic dermatitis (AD). By inhibiting IL-13 signaling, Ebglyss reduces inflammation and helps improve skin lesions in patients with moderate-to-severe AD. It is indicated for use in adults and pediatric patients aged 12 years and older who weigh at least 40 kg and whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Ebglyss can be used with or without topical corticosteroids.
| Fact Table | |
| Formula | C6476H9994N1726O2036S46 |
| License | EMA (2023), US FDA (2023) |
| Bioavailability | Subcutaneous: ~77% |
| Legal status | Prescription only |
| Chemical Name | Lebrikizumab |
| Elimination half-life | 18–25 days |
| Dosage (Strength) | 150 mg/mL prefilled syringe or autoinjector |
| Pregnancy | Use only if clearly needed – no adequate human data |
| Brands | Ebglyss |
| Protein binding | High (monoclonal antibody) |
| PubChem CID | 121585681 |
| MedlinePlus | a622058 |
| ChEBI | Not listed |
| ATC code | D11AH07 |
| DrugBank | DB12310 |
| KEGG | D12348 |
| Routes of administration | Subcutaneous injection |
Ebglyss is administered via subcutaneous injection. The recommended dosing regimen is as follows:
Ebglyss is available as a 250 mg/2 mL solution in single-dose prefilled pens or syringes. Prior to initiating therapy, complete all age-appropriate vaccinations according to current immunization guidelines.
Ebglyss is contraindicated in patients with known hypersensitivity to lebrikizumab or any of its excipients.
Common side effects may include:
Serious side effects may include:
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews